BIOLAP:腹腔镜腹股沟疝修补术中生物补片与合成补片的随机多中心自身对照试验方案
BACKGROUND: Inguinal hernia repair is one of the most common surgical operations globally; more than 20 million groin herniae are repaired annually worldwide. Recurrence after an inguinal hernia operation is a considerable clinical problem.…
要点
- 自身对照设计可减少混杂因素,直接比较生物补片与合成补片。
- 主要终点为术后局部疼痛强度与 2 年复发疝发生率。
核心结论
- 研究假设生物补片可减少术后疼痛,且在复发率方面不劣于合成补片。
研究设计与样本
- 同一患者双侧疝随机分配一侧用生物补片、另一侧用合成补片,患者不知晓每侧材料类型。
关键数值与推荐
- 主要终点为术后局部疼痛强度和 2 年复发疝发生率。
- 试验注册号:德国临床试验注册中心 DRKS00010178,注册日期 2016 年 6 月 16 日。
临床怎么用
- 目前合成补片是腹股沟疝修补的标准术式,生物补片在慢性疼痛方面可能具有优势。
- 该试验结果可能对疝修补标准产生直接影响,因指南强调需要生物补片可靠数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inguinal hernia repair is one of the most common surgical operations globally; more than 20 million groin herniae are repaired annually worldwide. Recurrence after an inguinal hernia operation is a considerable clinical problem. Another remaining problem after hernia surgery is the occurrence of chronic pain. Up to now, the use of synthetic meshes is the standard procedure, but there is increasing evidence that biological meshes could be advantageous concerning the occurrence of chronic pain due to different postoperative remodeling, without the disadvantages of a life-long implant. We hypothesize that the use of a biological mesh reduces postoperative pain without being inferior in terms of recurrence rate compared with a synthetic mesh. METHODS/DESIGN: The trial compares possible the advantages of biological matrices to synthetic meshes in laparo-endoscopic inguinal hernia repair. Four hundred and ninety-six patients with primary bilateral inguinal herniae in 20 German hernia centers will be enrolled. Biological mesh is used for one of the bilateral herniae, the other side will be operated on with a synthetic mesh. Randomization will preset which side is repaired with which material and trial participants will not be informed about the location of each mesh type. The primary endpoints will be intensity of postoperative local pain and the incidence of recurrent hernia after 2 years. DISCUSSION: There is no reasonably sized trial that assesses the use of biological meshes in laparo-endoscopic inguinal hernia repair. Our self-controlled trial design allows a direct comparison of the two meshes with very few confounding factors as well as minimizing the exclusion criteria. As we compare CE-certified medical devices in their designated indication the medical risk is not different compared to routine clinical care. Due to the common nature of bilateral inguinal hernia, a high recruitment rate is achievable. Because guidelines for hernia repair have stressed the need for reliable data on the already frequent use of biological meshes, we can expect our trial to have a direct implication on hernia-repair standards. TRIAL REGISTRATION: German Clinical Trials Register, ID: DRKS00010178 . Registered on 16.June.2016. BIOLAP underwent full external peer review as part of the funding process with the German Research Foundation.
引用
- Seefeldt CS, Meyer JS, Knievel J, et al. BIOLAP: biological versus synthetic mesh in laparo-endoscopic inguinal hernia repair: study protocol for a randomized, multicenter, self-controlled clinical trial. Trials. 2019. PMID: 30651127. doi:10.1186/s13063-018-3122-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。